Literature DB >> 1386730

Effects of different expression and posttranslational modifications of myosin light chains on contractility of skinned human cardiac fibers.

I Morano1.   

Abstract

In the human ventricle two isoforms of the phosphorylatable myosin light chain (MPLC) are expressed. These two forms are designated with increasing acidity as LC-2 and LC-2*. In the normal human heart the relation between LC-2/LC-2*-expression is 70/30, suggesting the existence of three different myosin isoenzymes (MPLC-polymorphism) in the normal human ventricle. Both ventricular MPLC-isoforms are monophosphorylated, the LC-2 being higher phosphorylated than the LC-2*. In some patients with heart failure both MPLC isoforms were found to be completely dephosphorylated. In the human atrium a MPLC isoform is expressed which is different from the ventricular MPLC isoforms. The atrial MPLC isoform is mono- and diphosphorylated. Mono-phosphorylation of both the ventricular MPLC isoforms and the atrial MPLC isoform increased responsiveness as well as sensitivity of isometric tension generation of skinned fibers to Ca2+. Part of this effect could be explained by changing the cross-bridge-cycling rate: MPLC increased fapp, the rate-constant for the transition of cross-bridges from the non-force into the force-generating state, thus increasing the amount of force-generating cross-bridge states at a given [Ca2+]. Monophosphorylation of the MPLC isoforms did not change maximal shortening velocity.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1386730     DOI: 10.1007/978-3-642-72474-9_11

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  22 in total

1.  A novel, in-solution separation of endogenous cardiac sarcomeric proteins and identification of distinct charged variants of regulatory light chain.

Authors:  Sarah B Scruggs; Rick Reisdorph; Mike L Armstrong; Chad M Warren; Nichole Reisdorph; R John Solaro; Peter M Buttrick
Journal:  Mol Cell Proteomics       Date:  2010-05-05       Impact factor: 5.911

2.  Neonatal asphyxia induces the nitration of cardiac myosin light chain 2 that is associated with cardiac systolic dysfunction.

Authors:  Adrian Doroszko; Dorota Polewicz; Virgilio J J Cadete; Jolanta Sawicka; Michelle Jones; Danuta Szczesna-Cordary; Po-Yin Cheung; Grzegorz Sawicki
Journal:  Shock       Date:  2010-12       Impact factor: 3.454

3.  Biochemical and myofilament responses of the right ventricle to severe pulmonary hypertension.

Authors:  Lori A Walker; John S Walker; Amelia Glazier; Dale R Brown; Kurt R Stenmark; Peter M Buttrick
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-05-27       Impact factor: 4.733

4.  Mouse and computational models link Mlc2v dephosphorylation to altered myosin kinetics in early cardiac disease.

Authors:  Farah Sheikh; Kunfu Ouyang; Stuart G Campbell; Robert C Lyon; Joyce Chuang; Dan Fitzsimons; Jared Tangney; Carlos G Hidalgo; Charles S Chung; Hongqiang Cheng; Nancy D Dalton; Yusu Gu; Hideko Kasahara; Majid Ghassemian; Jeffrey H Omens; Kirk L Peterson; Henk L Granzier; Richard L Moss; Andrew D McCulloch; Ju Chen
Journal:  J Clin Invest       Date:  2012-03-19       Impact factor: 14.808

5.  Cardiac myosin light chain is phosphorylated by Ca2+/calmodulin-dependent and -independent kinase activities.

Authors:  Audrey N Chang; Pravin Mahajan; Stefan Knapp; Hannah Barton; H Lee Sweeney; Kristine E Kamm; James T Stull
Journal:  Proc Natl Acad Sci U S A       Date:  2016-06-20       Impact factor: 11.205

Review 6.  Role of myosin light chain phosphatase in cardiac physiology and pathophysiology.

Authors:  Audrey N Chang; Kristine E Kamm; James T Stull
Journal:  J Mol Cell Cardiol       Date:  2016-10-11       Impact factor: 5.000

7.  Single-molecule analysis reveals that regulatory light chains fine-tune skeletal myosin II function.

Authors:  Arnab Nayak; Tianbang Wang; Peter Franz; Walter Steffen; Igor Chizhov; Georgios Tsiavaliaris; Mamta Amrute-Nayak
Journal:  J Biol Chem       Date:  2020-04-09       Impact factor: 5.157

8.  Differential inhibition by the Rho kinase inhibitor Y-27632 of the increases in contractility and Ca2+ transients induced by endothelin-1 in rabbit ventricular myocytes.

Authors:  Li Chu; Ikuo Norota; Masao Endoh
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-04-20       Impact factor: 3.000

Review 9.  Functions of myosin light chain-2 (MYL2) in cardiac muscle and disease.

Authors:  Farah Sheikh; Robert C Lyon; Ju Chen
Journal:  Gene       Date:  2015-06-12       Impact factor: 3.688

Review 10.  Getting the skinny on thick filament regulation in cardiac muscle biology and disease.

Authors:  Farah Sheikh; Robert C Lyon; Ju Chen
Journal:  Trends Cardiovasc Med       Date:  2013-08-19       Impact factor: 6.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.